[1]
Setiawansyah, A. dkk. 2024. Aaptamine Enhanced Doxorubicin Activity on B-Cell Lymphoma 2 (Bcl-2): A Multi-Structural Molecular Docking Study. Ad-Dawaa: Journal of Pharmaceutical Sciences. 7, 1 (Jun 2024), 1–10. DOI:https://doi.org/10.24252/djps.v7i1.46796.